MedTrace Logo

Outcomes After Albumin Vs Lactated Ringer's Solution in CABG and AVR Procedures

NCT04652375 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 131

Last updated 2024-09-23

No results posted yet for this study

Summary

This is a prospective, randomized, double-blinded study to compare the use of albumin versus lactated Ringer's solution in patients undergoing coronary artery bypass graft surgery and in patients undergoing aortic valve replacement surgery and evaluate the incidence of acute kidney injury as a primary outcome.

Conditions

  • Coronary Artery Bypass Graft Surgery
  • Aortic Valve Replacement

Interventions

OTHER

Albumin Solution

Participants will receive Albumin solution for fluid resuscitation post-surgery.

OTHER

Lactated Ringer's Solution

Participants will receive Lactated Ringer's solution for fluid resuscitation post-surgery.

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Hossam Tantway, MD · Yale University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-01
Primary Completion
2022-07-26
Completion
2022-07-26

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04652375 on ClinicalTrials.gov